Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Tachyarrhythmia
Interventions
DEVICE

Implantable cardioverter-defibrillator

Trial Locations (10)

4031

Kantonspital Basel, Abteilung für Kardiologie, Basel

10365

Sana Klinikum Lichtenberg, Berlin

12200

Charité-Universitätsmedizin Campus Benjamin Franklin, Med. Klinik II / Kardiologie, Berlin

13437

Vivantes Netzwerk für Gesundheit GmbH (Humboldt), Berlin

30625

Medizinische Hochschule Hannover, Hanover

37099

Georg-August-Universität, Universitätsklinikum Göttingen, Göttingen

44137

St. Johannes Hospital, Medizinische Klinik I, Dortmund

48129

Westfälische Wilhelms-Universität, Münster

53115

Kardiologische Praxis, Bonn

78050

Klinikum der Stadt Villingen Schwenningen GmbH, Villingen

All Listed Sponsors
lead

Biotronik SE & Co. KG

INDUSTRY

NCT00324662 - Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA) | Biotech Hunter | Biotech Hunter